Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Clinical Chemistry|December 1, 1976
A spot test for uroporphyrinogen I synthase, the enzyme that is deficient in intermittent acute porphyriaH M Schumaker, P V Tishler, D J Knighton
The American Journal of Psychiatry|December 1, 1985
High prevalence of intermittent acute porphyria in a psychiatric patient populationP V Tishler, B Woodward, J O'Connor, et al.
Life Sciences|July 23, 1999
The effect of therapeutic drugs and other pharmacologic agents on activity of porphobilinogen deaminase, the enzyme that is deficient in intermittent acute porphyriaP V Tishler
Neurology|September 1, 1975
A family with coexistent von Recklinghausen's neurofibromatosis and von Hippel-Lindau's disease. Diseases possibly derived from a common geneP V Tishler
Clinical Genetics|October 1, 1979
Healthy female carriers of a gene for the Alport syndrome: importance for genetic counselingP V Tishler
Birth Defects Original Article Series|January 1, 1974
The genetics of the Alport syndromeP V Tishler, B Rosner
Methods and Findings in Experimental and Clinical Pharmacology|July 1, 1984
Sorbent therapy of the porphyrias. III. Comparative efficacy of experimental plasma perfusion with several commercial hemoperfusion cartridgesP V Tishler, S H Winston
Methods and Findings in Experimental and Clinical Pharmacology|November 1, 1990
Rapid improvement in the chemical pathology of congenital erythropoietic porphyria with treatment with superactivated charcoalP V Tishler, S H Winston
Methods and Findings in Experimental and Clinical Pharmacology|September 1, 1985
Sorbent therapy of the porphyrias. IV. Adsorption of porphyrins by sorbents in vitroP V Tishler, S H Winston
Enzyme|January 1, 1975
Studies on the mechanism of induction of mitochondrial alpha-glycerophosphate dehydrogenase by thyroid hormone. The role of differential gene activationP V Tishler, M E Hammond
Pageof 5